Clinical Outcomes of Angiotensin II Therapy in Vasoplegic Shock: A Systematic Review and Meta-Analysis
Ans Alamami(Hamad Medical Corporation), Ahmed Labib(Hamad Medical Corporation), Bara M Al-Qudah(Hamad Medical Corporation), Abdelkarim Alammora(Hamad Medical Corporation), Alaa Rahhal(Hamad Medical Corporation), Hashim Mohammad(Hamad Medical Corporation), Ahmed Shebani(Hamad Medical Corporation), Amr Salah Omar(Hamad Medical Corporation)
Cited by 5
Related Papers
Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms
|Diagnostics|2023|15
The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
|British Journal of Cancer|2008|13
<i>TBX5</i> variant with the novel phenotype of mixed‑type total anomalous pulmonary venous return in Holt‑Oram Syndrome and variable intrafamilial heart defects
|Molecular Medicine Reports|2022|7
Extending the spectrum of <i>CLRN1</i>‐ and <i>ABCA4</i>‐associated inherited retinal dystrophies caused by novel and recurrent variants using exome sequencing
|Molecular Genetics & Genomic Medicine|2020|5